This is a StreetInsider.com Premium Only Page

Regeneron (REGN) – StreetInsider.com Reports

Nov 28, 2023 07:46 AM Regeneron Pharma (REGN) PT Raised to $937 at Jefferies

Nov 27, 2023 05:03 AM Regeneron (REGN) Reports Dupixent Significantly Reduced COPD Exacerbations in Second Positive Phase 3 Trial

Nov 8, 2023 04:18 PM Deutsche Bank Starts Regeneron Pharma (REGN) at Hold

Nov 6, 2023 04:58 AM Regeneron Pharma (REGN) PT Raised to $915 at DZ Bank

Nov 3, 2023 08:30 AM Regeneron Pharma (REGN) PT Lowered to $914 at Morgan Stanley

Nov 3, 2023 08:07 AM Regeneron Pharma (REGN) PT Raised to $900 at TD Cowen

Nov 3, 2023 06:50 AM Regeneron Pharma (REGN) PT Raised to $1,066 at Canaccord Genuity

Nov 3, 2023 06:27 AM Regeneron Pharma (REGN) PT Lowered to $837 at RBC Capital

Nov 3, 2023 01:59 AM Raymond James Upgrades Regeneron Pharma (REGN) to Outperform

Nov 2, 2023 04:24 PM Regeneron Pharma (REGN) PT Raised to $797 at Baird

Nov 2, 2023 04:19 PM Regeneron Pharma (REGN) PT Raised to $895 at Piper Sandler

Nov 2, 2023 08:47 AM Regeneron Pharma (REGN) PT Raised to $907 at UBS

Nov 2, 2023 07:52 AM Starbucks, DoorDash, Roku, Qualcomm rise premarket; Peloton, Moderna fall

Nov 2, 2023 06:48 AM Regeneron sees strong initial demand for higher-dose Eylea

Oct 26, 2023 04:01 PM Regeneron (REGN) Reports Prelim Results Showing Gene Therapy Improves Auditory Responses in Child with Profound Genetic Hearing Loss

Oct 23, 2023 08:41 AM Regeneron Pharma (REGN) survey shows Eylea franchise in 'good shape' - Piper Sandler

Oct 11, 2023 09:00 AM Regeneron Pharma (REGN) PT Raised to $915 at Morgan Stanley

Oct 5, 2023 09:43 AM Regeneron (REGN) Presents Results from Two-year Results from Pivotal PULSAR Trial of EYLEA HD

Oct 3, 2023 07:02 AM Regeneron (REGN) and Intellia (NTLA) Announce Expanded Research Collaboration to Develop CRISPR-Based Therapies for the Treatment of Neurological and Muscular Diseases

Sep 29, 2023 08:31 AM Regeneron (REGN) Reports Odronextamab BLA Accepted for FDA Priority Review

Sep 25, 2023 08:35 AM Regeneron (REGN) Completes Acquisition of Decibel Therapeutics

Sep 20, 2023 09:02 AM AbCellera (ABCL) Expands Multi-Target Antibody Discovery Collaboration with Regeneron (REGN)

Sep 15, 2023 07:20 AM WestPark Capital Starts Regeneron Pharma (REGN) at Hold

Sep 9, 2023 09:46 AM Regeneron (REGN) Appoints Kathryn Guarini and David P. Schenkein to its Board

Sep 9, 2023 09:46 AM Regeneron (REGN) Provides Update on Planned CFO Change

Aug 22, 2023 02:16 PM Regeneron (REGN) Announces Agreement with BARDA Supporting Development of Next-Generation Antibody Therapy for COVID-19 Prevention

Aug 21, 2023 09:25 AM Canaccord Genuity Upgrades Regeneron Pharma (REGN) to Buy

Aug 21, 2023 08:02 AM Regeneron (REGN) gets its 'mojo back' after FDA approves Eylea HD

Aug 21, 2023 06:33 AM Regeneron Pharma (REGN) PT Raised to $980 at Wells Fargo

Aug 21, 2023 06:27 AM Regeneron Pharma (REGN) PT Raised to $1,050 at Oppenheimer

Aug 21, 2023 06:26 AM Regeneron Pharma (REGN) PT Raised to $830 at RBC Capital

Aug 21, 2023 06:16 AM Regeneron Pharma (REGN) PT Raised to $1,050 at Oppenheimer

Aug 21, 2023 06:11 AM Regeneron (REGN) announces FDA approval for EYLEA HD

Aug 21, 2023 06:10 AM Regeneron Pharma (REGN) PT Raised to $985 at BMO Capital

Aug 21, 2023 04:03 AM Regeneron Pharma (REGN) PT Raised to $925 at Barclays

Aug 18, 2023 02:08 PM US FDA approves Regeneron's ultra-rare blood disease drug

Aug 18, 2023 01:45 PM Regeneron (REGN) Granted FDA Approval of Veopoz as Treatment for Children and Adults with CHAPLE Disease

Aug 17, 2023 08:30 AM Regeneron (REGN) Receives EMA Filing Acceptance for Treatment of Relapsed/Refractory Follicular Lymphoma and Diffuse Large B-cell Lymphoma

Aug 9, 2023 07:32 AM Regeneron (REGN) to Acquire Decibel Therapeutics (DBTX) for Over $4 Per Share

Aug 4, 2023 09:16 AM Regeneron Pharma (REGN) PT Lowered to $895 at UBS

Aug 4, 2023 08:17 AM Regeneron Pharma (REGN) PT Raised to $912 at Morgan Stanley

Aug 4, 2023 07:50 AM Regeneron Pharma (REGN) PT Raised to $950 at Oppenheimer

Aug 4, 2023 06:27 AM Regeneron Pharma (REGN) PT Raised to $820 at RBC Capital

Aug 3, 2023 08:13 AM Qualcomm, PayPal and Roku fall premarket; DoorDash, Moderna rise

Aug 3, 2023 06:33 AM Regeneron (REGN) Tops Q2 EPS by 39c, beats revenue

Jul 24, 2023 09:23 AM Regeneron Pharma (REGN) PT Lowered to $912 at UBS

Jul 11, 2023 07:42 AM Regeneron Pharma (REGN) PT Lowered to $897 at Morgan Stanley

Jul 5, 2023 03:24 PM Regeneron Pharma (REGN) PT Lowered to $795 at Cantor Fitzgerald

Jun 28, 2023 01:57 PM Midday movers: Nvidia, AeroVironment, General Mills and more

Jun 28, 2023 10:15 AM Catalent (CTLT) Facility Underwent Inspection For Regeneron's (REGN) Eylea - Bloomberg